These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1198751)

  • 1. [Granulomatous liver disease induced by phenylbutazone].
    Anker N; Skovbjerg H
    Ugeskr Laeger; 1975 Dec; 137(51):3038-9. PubMed ID: 1198751
    [No Abstract]   [Full Text] [Related]  

  • 2. Granulomas and cholestatic--hepatocellular injury associated with phenylbutazone. Report of two cases.
    Ishak KG; Kirchner JP; Dhar JK
    Am J Dig Dis; 1977 Jul; 22(7):611-7. PubMed ID: 879127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenylbutazone liver injury: a clinical-pathologic survey of 23 cases and review of the literature.
    Benjamin SB; Ishak KG; Zimmerman HJ; Grushka A
    Hepatology; 1981; 1(3):255-63. PubMed ID: 7286906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylbutazone-induced hepatitis.
    Mayer TR
    Minn Med; 1979 May; 62(5):349-50. PubMed ID: 440260
    [No Abstract]   [Full Text] [Related]  

  • 5. [Liver damage due to phenylbutazone and chlorpropamide].
    Grottum KA
    Tidsskr Nor Laegeforen; 1966 Aug; 86(16):1096-8. PubMed ID: 5919203
    [No Abstract]   [Full Text] [Related]  

  • 6. Sarcoid granulomas associated with phenylbutazone treatment.
    Lebacq EG; Desmet V
    Mt Sinai J Med; 1977; 44(6):778-81. PubMed ID: 145540
    [No Abstract]   [Full Text] [Related]  

  • 7. Morphological aspects of hepatitis induced by phenylbutazone derivatives. Observations on two cases.
    Coltorti M; Cuccurullo L; Del Vecchio Blanco C
    Acta Hepatosplenol; 1971; 18(3):206-15. PubMed ID: 5089187
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxic hepatitis following phenylbutazone therapy.
    Muscat-Baron JM; Freeman DM
    Br J Clin Pract; 1966 Aug; 20(8):437-9. PubMed ID: 5944035
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxic hepatitis following the use of phenylbutazone (butazolidan) report of a fatal case.
    ANTREASIAN B; ROTH MI; TAVEL ME
    J Indiana State Med Assoc; 1958 Jun; 51(6):761-5. PubMed ID: 13549760
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multiple manifestations of intolerance of a combination of anti-inflammatory drugs. Role of phenylbutazone].
    Tolot F; Prost G; Guignot B; Pelletier M
    Sem Hop; 1975 Dec; 51(48):2555-60. PubMed ID: 175502
    [No Abstract]   [Full Text] [Related]  

  • 11. Carbamazepine induced granulomatous hepatitis.
    Swinburn BA; Croxson MS; Miller MV; Crawford KB
    N Z Med J; 1986 Mar; 99(797):167. PubMed ID: 3457299
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical and morphological findings on 2 cases of icterus induced by butazolidines].
    Coltorti M; Cuccurullo L; Del Vecchio-Blanco C
    Policlinico Prat; 1970 Mar; 77(10):309-24. PubMed ID: 5436754
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenylbutazone and hepatitis.
    Fowler PD; Woolf D; Alexander S
    Rheumatol Rehabil; 1975 May; 14(2):71-5. PubMed ID: 1145012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Iatrogenic damage in therapy with phenylbutazone].
    Visintini E
    Minerva Med; 1971 Feb; 62(16):792-6. PubMed ID: 4251443
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatic cholestasis due to benetazone].
    Krtek V; Chlumský J
    Vnitr Lek; 1979 Feb; 25(2):152-4. PubMed ID: 570757
    [No Abstract]   [Full Text] [Related]  

  • 16. Ticlopidine-induced granulomatous hepatitis.
    Ruiz-Valverde P; Zafon C; Segarra A; Ribera R; Piera L
    Ann Pharmacother; 1995 Jun; 29(6):633-4. PubMed ID: 7663041
    [No Abstract]   [Full Text] [Related]  

  • 17. [Multiple manifestations of intolerance in association with anti-inflammatory agents. Role of phenylbutazone].
    Tolot F; Prost G; Guignot B; Pelletier M
    Sem Hop Ther; 1976 Mar; 52(3):185-90. PubMed ID: 795032
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatal hepatitis due to phenylbutazone in a child.
    Dhatt PS; Singh H; Gupta HL; Arya RK
    Indian J Pediatr; 1973 Aug; 40(307):293-4. PubMed ID: 4769816
    [No Abstract]   [Full Text] [Related]  

  • 19. Granulomatous hepatitis as a manifestation of quinidine hypersensitivity.
    Bramlet DA; Posalaky Z; Olson R
    Arch Intern Med; 1980 Mar; 140(3):395-7. PubMed ID: 7362358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced granulomatous hepatitis.
    McMaster KR; Hennigar GR
    Lab Invest; 1981 Jan; 44(1):61-73. PubMed ID: 7453131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.